Patent: 12,311,015
✉ Email this page to a colleague
Summary for Patent: 12,311,015
| Title: | Stable liquid thrombin compositions |
| Abstract: | The present invention provides methods for large scale preparation of sterile stable liquid thrombin composition comprised of glycerol; stable liquid thrombin compositions; and hemostatic composition and kits. The present invention further provides hemostatic compositions comprised of liquid thrombin, glycerol and gelatin. Further provided herein is a method for the large-scale production of a sterile liquid thrombin composition comprised of glycerol. |
| Inventor(s): | Erez Ilan, Omri Faingold, Sivan Doron |
| Assignee: | Omrix Biopharmaceuticals Ltd |
| Application Number: | US18/418,690 |
| Patent Claims: | see list of patent claims |
Details for Patent 12,311,015
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | Solution | 125247 | August 27, 2007 | 12,311,015 | 2044-01-22 |
| Omrix Biopharmaceuticals Ltd | EVITHROM | thrombin, topical (human) | For Injection | 125247 | September 17, 2009 | 12,311,015 | 2044-01-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 12,311,015
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2020035848 | ⤷ Start Trial |
| United States of America | 2024173388 | ⤷ Start Trial |
| United States of America | 2020054720 | ⤷ Start Trial |
| United States of America | 11911448 | ⤷ Start Trial |
| Mexico | 2021001827 | ⤷ Start Trial |
| South Korea | 20210046699 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
